Apoptosis-inducing agent for the treatment of cancer and immune and autoimmune diseases
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Saved in:
| Main Authors | , , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
15.11.2016
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. |
|---|---|
| AbstractList | Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. |
| Author | Sullivan Gerard M Elmore Steven W Kunzer Aaron R |
| Author_xml | – fullname: Elmore Steven W – fullname: Sullivan Gerard M – fullname: Kunzer Aaron R |
| BookMark | eNqNijsOwkAMBbeAgt8dfIEUkDSUgED0gCgja_MSViL2Knbuj0A5ANWbGb1lmIkKFuF5yJpdLVmRpBljko64gzi1OpC_QD6Avf8WbSmyRAzE0lDq-1HwQx5dJ22SgQ22DvOW34bNtKtAl_P9dC2QtYZljhB4_bjtq31Zldvjrvzj8gE_6jui |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | US9493431B2 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_US9493431B23 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 14:51:16 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_US9493431B23 |
| Notes | Application Number: US201514855176 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161115&DB=EPODOC&CC=US&NR=9493431B2 |
| ParticipantIDs | epo_espacenet_US9493431B2 |
| PublicationCentury | 2000 |
| PublicationDate | 20161115 |
| PublicationDateYYYYMMDD | 2016-11-15 |
| PublicationDate_xml | – month: 11 year: 2016 text: 20161115 day: 15 |
| PublicationDecade | 2010 |
| PublicationYear | 2016 |
| RelatedCompanies | AbbVie Inc |
| RelatedCompanies_xml | – name: AbbVie Inc |
| Score | 3.0670717 |
| Snippet | Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | Apoptosis-inducing agent for the treatment of cancer and immune and autoimmune diseases |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161115&DB=EPODOC&locale=&CC=US&NR=9493431B2 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH-MKepNp-L8Igfprdi1aVkPRezHGMI-cKvuNpIsHb20Ze3w3_eldNWL3pI8CMkLL-_3kvxeAJ4Myl0U2bo7dG2dckPoTJiObgohLYdbkpqK4DyZOuOYvq3sVQfSAxemzhP6VSdHRIsSaO9VvV8XP4dYYf22snzmKTblL6OlF2pNdIzwBRGOFvpeNJ-Fs0ALAi9eaNN3z6Wuhb7Sx936SKFolWY_-vAVKaX47VFG53A8x86y6gI6MuvBaXD4eK0HJ5PmvhuLjemVl_D5WuRFlZdpqWMYvUf5ljDFiyIIOwnCONK-GSd5QoRazR1h2YakigIi6yLbV3lTbW5myisgo2gZjHUc4brVxjpetHOxrqGb5Zm8AZKYgkqDbTDkdCgbWhzdPtYHgrsMQXTSh_6f3dz-I7uDM6VWxb4b2PfQrXZ7-YBuuOKPtQK_Aexhjus |
| link.rule.ids | 230,309,786,891,25594,76903 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3PT8IwFH4haMSbokb82YPZbRG2brLDYmSDoPIrAsqNtKUzu2wLG_Hf97UZ6EVvbV_StG95fd_X9usA7pqUe2hyTK_tOSblTWEyYbmmJYS0XW5LaimB83Dk9uf0ZeEsKhBvtTD6ndAv_TgiRpTAeC_0ep39bGKF-m5lfs9jbEofezM_NEp2jPAFEY4RdvzuZByOAyMI_PnUGL35HvVszJUdXK33HpARaqb03lGilOx3Rukdwf4EO0uKY6jIpA61YPvjtTocDMvzbiyWoZefwMdTlmZFmse5iTR6g_ZPwpQuiiDsJAjjyO7OOEkjItTXXBOWrEisJCBSF9mmSMtqeTKTnwLpdWdB38QRLnfeWM6nu7nYZ1BN0kSeA4ksQWWTrZByupS1bY5pH-stwT2GIDpqQOPPbi7-sd1CrT8bDpaD59HrJRwqFyslXsu5gmqx3shrTMkFv9HO_AbAnpHV |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Apoptosis-inducing+agent+for+the+treatment+of+cancer+and+immune+and+autoimmune+diseases&rft.inventor=Elmore+Steven+W&rft.inventor=Sullivan+Gerard+M&rft.inventor=Kunzer+Aaron+R&rft.date=2016-11-15&rft.externalDBID=B2&rft.externalDocID=US9493431B2 |